JPWO2022244825A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022244825A5
JPWO2022244825A5 JP2023522709A JP2023522709A JPWO2022244825A5 JP WO2022244825 A5 JPWO2022244825 A5 JP WO2022244825A5 JP 2023522709 A JP2023522709 A JP 2023522709A JP 2023522709 A JP2023522709 A JP 2023522709A JP WO2022244825 A5 JPWO2022244825 A5 JP WO2022244825A5
Authority
JP
Japan
Prior art keywords
lipid
particle
particle according
protein
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023522709A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022244825A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/020745 external-priority patent/WO2022244825A1/ja
Publication of JPWO2022244825A1 publication Critical patent/JPWO2022244825A1/ja
Publication of JPWO2022244825A5 publication Critical patent/JPWO2022244825A5/ja
Pending legal-status Critical Current

Links

JP2023522709A 2021-05-19 2022-05-18 Pending JPWO2022244825A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021084669 2021-05-19
PCT/JP2022/020745 WO2022244825A1 (ja) 2021-05-19 2022-05-18 インフルエンザウイルス核酸脂質粒子ワクチン

Publications (2)

Publication Number Publication Date
JPWO2022244825A1 JPWO2022244825A1 (https=) 2022-11-24
JPWO2022244825A5 true JPWO2022244825A5 (https=) 2025-05-22

Family

ID=84141641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023522709A Pending JPWO2022244825A1 (https=) 2021-05-19 2022-05-18

Country Status (7)

Country Link
US (1) US20240238404A1 (https=)
EP (1) EP4342490A4 (https=)
JP (1) JPWO2022244825A1 (https=)
KR (1) KR20240009952A (https=)
CN (1) CN117642179A (https=)
TW (1) TW202313101A (https=)
WO (1) WO2022244825A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025092866A1 (zh) * 2023-10-31 2025-05-08 仁景(苏州)生物科技有限公司 一种多价流感mRNA疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201534578A (zh) * 2013-07-08 2015-09-16 Daiichi Sankyo Co Ltd 新穎脂質
PL4023249T3 (pl) 2014-04-23 2025-03-10 Modernatx, Inc. Szczepionki z kwasem nukleinowym
JP7384512B2 (ja) * 2015-10-22 2023-11-21 モデルナティエックス インコーポレイテッド 広域インフルエンザウイルスワクチン
CA3040337A1 (en) 2016-10-26 2018-05-03 Curevac Ag Lipid nanoparticle mrna vaccines
WO2019191780A1 (en) * 2018-03-30 2019-10-03 Arcturus Therapeutics, Inc. Lipid particles for nucleic acid delivery
US12083174B2 (en) * 2018-08-17 2024-09-10 Glaxosmithkline Biologicals Sa Immunogenic compositions and uses thereof
EP4059515A4 (en) * 2019-11-15 2024-02-14 Daiichi Sankyo Company, Limited Nucleic acid lipid particle vaccine encapsulating hpv mrna

Similar Documents

Publication Publication Date Title
US12239735B2 (en) Lipid nanoparticles for delivering mRNA vaccines
JP4800485B2 (ja) ポリヌクレオチドベースのワクチンに対する免疫応答を増強するためのアジュバント組成物および方法
US20230043128A1 (en) Multivalent influenza vaccines
JP4764426B2 (ja) カチオン性脂質および使用方法
JP5835741B2 (ja) 抗原または薬物送達複合体
JP2023550600A (ja) mRNAワクチンを送達するための脂質ナノ粒子
CN118338911A (zh) 人偏肺病毒疫苗
KR20010020161A (ko) 소포성 복합체와 이의 제조 및 사용방법
Higuchi et al. Material design for next-generation mRNA vaccines using lipid nanoparticles
WO2025001900A1 (zh) 可离子化脂质及其应用
JPWO2021251453A5 (https=)
JPWO2022244815A5 (https=)
JPWO2022244825A5 (https=)
WO2024094027A1 (zh) 用于增强核酸递送的组合物
JP2025538206A (ja) 脂質-荷電分子コンジュゲート、吸入可能な脂質ナノ粒子、その製造方法、および使用
CN120813372A (zh) 针对冠状病毒的疫苗
CN117580568A (zh) 多价流感疫苗
Aldosari et al. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics 2021, 13, 206
CN114601922A (zh) 一种含5-甲基嘧啶-2,4(1h,3h)-二酮类衍生物的纳米粒及其制备方法和用途
Tavano et al. Nanovesicular formulations for cancer gene therapy
EP4442257A1 (en) Nanoparticle compositions comprising one or more variants of poly(d,l-lactic-co-glycolic acid)
CN114605338B (zh) 一种含尿嘧啶衍生物的纳米粒、核酸纳米复合物及其制备方法和用途
CN114591386B (zh) 一种含尿苷衍生物的纳米粒、核酸纳米复合物及其制备方法和用途
CN114933565A (zh) 一种核碱基衍生物纳米粒及其组合物
HK40103490A (zh) 递送自复制rna分子的方法